Pharmaceutics Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar (M.P.) 470003, India.
Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):478-90. doi: 10.1016/j.addr.2009.11.018. Epub 2009 Nov 12.
Development of an effective drug delivery approach for the treatment of HIV/AIDS is a global challenge. The conventional drug delivery approaches including Highly Active Anti Retroviral Therapy (HAART) have increased the life span of the HIV/AIDS patient. However, the eradication of HIV is still not possible with these approaches due to some limitations. Emergence of polymeric and non-polymeric nanotechnological approaches can be opportunistic in this direction. Polymeric carriers like, dendrimers and nanoparticles have been reported for the targeting of anti HIV drugs. The synthetic pathways as well polymeric framework create some hurdles in their successful formulation development as well as in the possible drug delivery approaches. In the present article, we have discussed the general physiological aspects of the infection along with the relevance of non-polymeric nanocarriers like liposomes, solid lipid nanoparticles (SLN), ethosomes, etc. in the treatment of this disastrous disease.
开发有效的药物递送方法来治疗艾滋病是一个全球性的挑战。传统的药物递送方法,包括高效抗逆转录病毒疗法(HAART),已经延长了艾滋病患者的寿命。然而,由于一些限制,这些方法仍然无法彻底消灭 HIV。聚合物和非聚合物纳米技术方法的出现可能为这一方向提供机会。报道了聚合物载体,如树枝状大分子和纳米颗粒,用于靶向抗 HIV 药物。它们的合成途径以及聚合物框架在其成功的制剂开发以及可能的药物递送方法中都存在一些障碍。在本文中,我们讨论了感染的一般生理方面,以及非聚合物纳米载体,如脂质体、固体脂质纳米粒(SLN)、醇质体等,在治疗这种灾难性疾病中的相关性。